Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL

Yuxin Hong(Nanjing University of Chinese Medicine), Juan Li(Nanjing University of Chinese Medicine)
Frontiers in Pharmacology
August 30, 2024
Cited by 1


Related Papers